<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35301367</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1<sup>G93A</sup> mice.</ArticleTitle><Pagination><StartPage>4630</StartPage><MedlinePgn>4630</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">4630</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-08455-y</ELocationID><Abstract><AbstractText>miRNAs are necessary for neuromuscular junction (NMJ) health; however, little is known about the proteins required for their activity in this regard. We examined expression of Argonaute 2 (Ago2) and miRNA biogenesis genes in skeletal muscles during development, following nerve injury and in the SOD1<sup>G93A</sup> ALS mouse model. We found that these genes are enriched in neonate muscles and in adult muscles following nerve injury. Despite widespread NMJ deterioration, these genes were not increased in muscles of SOD1<sup>G93A</sup> mice. We also found that Ago2 distribution is linked to maturation, innervation, and health of NMJs. Ago2 increasingly concentrates in synaptic regions during NMJ maturation, disperses following experimental denervation and reconcentrates at the NMJ upon reinnervation. Similar to experimentally denervated muscles, a homogenous distribution of Ago2 was observed in SOD1<sup>G93A</sup> muscle fibers. To determine if Ago2 is necessary for the health of adult muscles, we excised Ago2 from Ago2<sup>fl/fl</sup> mice using adeno-associated virus mediated Cre recombinase expression. We observed modest changes in muscle histology after 3&#xa0;months of Ago2 knockdown. Together, these data provide critical insights into the role of Ago2 and miRNA biogenesis genes in healthy and ALS-afflicted skeletal muscles and NMJs.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Dillon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Biology, Cell Biology, &amp; Biochemistry Graduate Program, Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massopust</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St, Providence, RI, 02903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taetzsch</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St, Providence, RI, 02903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez</LastName><ForeName>Gregorio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, 70 Ship St, Providence, RI, 02903, USA. gregorio_valdez@brown.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Translational Neuroscience, Robert J. and Nancy D. Carney Institute for Brain Science and Brown Institute for Translational Science, Brown University, Providence, RI, USA. gregorio_valdez@brown.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Warren Alpert Medical School of Brown University, Providence, USA. gregorio_valdez@brown.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AG041688</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG055545</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21NS106313</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG051501</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C526735">Ago2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060565">Argonaute Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060565" MajorTopicYN="N">Argonaute Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>18</Day><Hour>5</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35301367</ArticleId><ArticleId IdType="pmc">PMC8931107</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-08455-y</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-08455-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meister G. Argonaute proteins: Functional insights and emerging roles. Nat. Rev. Genet. 2013;14:447&#x2013;459. doi: 10.1038/nrg3462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3462</ArticleId><ArticleId IdType="pubmed">23732335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M, Kim VN. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014;15:509&#x2013;524. doi: 10.1038/nrm3838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009;11:228&#x2013;234. doi: 10.1038/ncb0309-228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb0309-228</ArticleId><ArticleId IdType="pubmed">19255566</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004;305:1437&#x2013;1441. doi: 10.1126/science.1102513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1102513</ArticleId><ArticleId IdType="pubmed">15284456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessel D, et al. Germline AGO2 mutations impair RNA interference and human neurological development. Nat. Commun. 2020;11:1&#x2013;14. doi: 10.1038/s41467-020-19572-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19572-5</ArticleId><ArticleId IdType="pmc">PMC7670403</ArticleId><ArticleId IdType="pubmed">33199684</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajgor D, Sanderson TM, Amici M, Collingridge GL, Hanley JG. NMDAR-dependent Argonaute 2 phosphorylation regulates mi RNA activity and dendritic spine plasticity. EMBO J. 2018;37:e97943. doi: 10.15252/embj.201797943.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797943</ArticleId><ArticleId IdType="pmc">PMC5983126</ArticleId><ArticleId IdType="pubmed">29712715</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradis-Isler N, Boehm J. NMDA receptor-dependent dephosphorylation of serine 387 in Argonaute 2 increases its degradation and affects dendritic spine density and maturation. J. Biol. Chem. 2018;293:9311&#x2013;9325. doi: 10.1074/jbc.RA117.001007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001007</ArticleId><ArticleId IdType="pmc">PMC6005451</ArticleId><ArticleId IdType="pubmed">29735530</ArticleId></ArticleIdList></Reference><Reference><Citation>Neppl RL, Kataoka M, Wang D-Z. Crystallin-&#x3b1;B regulates skeletal muscle homeostasis via modulation of argonaute2 activity. J. Biol. Chem. 2014;289:17240&#x2013;17248. doi: 10.1074/jbc.M114.549584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.549584</ArticleId><ArticleId IdType="pmc">PMC4059164</ArticleId><ArticleId IdType="pubmed">24782307</ArticleId></ArticleIdList></Reference><Reference><Citation>Horak M, Novak J, Bienertova-Vasku J. Muscle-specific microRNAs in skeletal muscle development. Dev. Biol. 2016;410:1&#x2013;13. doi: 10.1016/j.ydbio.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.12.013</ArticleId><ArticleId IdType="pubmed">26708096</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Liu N, van Rooij E, Olson EN. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 2009;21:461&#x2013;469. doi: 10.1016/j.ceb.2009.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2009.01.029</ArticleId><ArticleId IdType="pmc">PMC2692369</ArticleId><ArticleId IdType="pubmed">19278845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, et al. Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci. Rep. 2018;8:1&#x2013;15. doi: 10.1038/s41598-018-23139-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pmc">PMC5884852</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimon R, et al. Mir126-5p downregulation facilitates axon degeneration and nmj disruption via a non-cell-autonomous mechanism in ALS. J. Neurosci. 2018;38:5478&#x2013;5494. doi: 10.1523/JNEUROSCI.3037-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3037-17.2018</ArticleId><ArticleId IdType="pmc">PMC6001038</ArticleId><ArticleId IdType="pubmed">29773756</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G, Heyer MP, Feng G, Sanes JR. The role of muscle microRNAs in repairing the neuromuscular junction. PLoS ONE. 2014;9:e93140. doi: 10.1371/journal.pone.0093140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093140</ArticleId><ArticleId IdType="pmc">PMC3963997</ArticleId><ArticleId IdType="pubmed">24664281</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, et al. Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice. Muscle Nerve. 2018;57:838&#x2013;847. doi: 10.1002/mus.26039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26039</ArticleId><ArticleId IdType="pubmed">29236291</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill EM, et al. The conserved microRNA miR-34 regulates synaptogenesis via coordination of distinct mechanisms in presynaptic and postsynaptic cells. Nat. Commun. 2020;11:1&#x2013;13. doi: 10.1038/s41467-019-13993-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13993-7</ArticleId><ArticleId IdType="pmc">PMC7046720</ArticleId><ArticleId IdType="pubmed">32107390</ArticleId></ArticleIdList></Reference><Reference><Citation>Loya CM, McNeill EM, Bao H, Zhang B, Van Vactor D. miR-8 controls synapse structure by repression of the actin regulator enabled. Development. 2014;141:1864&#x2013;1874. doi: 10.1242/dev.105791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.105791</ArticleId><ArticleId IdType="pmc">PMC3994775</ArticleId><ArticleId IdType="pubmed">24718988</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalkin W, Taetzsch T, Valdez G. The fibular nerve injury method: A reliable assay to identify and test factors that repair neuromuscular junctions. J. Vis. Exp. 2016 doi: 10.3791/54186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/54186</ArticleId><ArticleId IdType="pmc">PMC5091792</ArticleId><ArticleId IdType="pubmed">27585036</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha MC, Pousinha PA, Correia AM, Sebasti&#xe3;o AM, Ribeiro JA. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS ONE. 2013;8:e73846. doi: 10.1371/journal.pone.0073846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0073846</ArticleId><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Taetzsch T, Tenga MJ, Valdez G. Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS. J. Neurosci. 2017;37:70&#x2013;82. doi: 10.1523/JNEUROSCI.2992-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2992-16.2016</ArticleId><ArticleId IdType="pmc">PMC5214636</ArticleId><ArticleId IdType="pubmed">28053031</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi S, et al. DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol. Med. 2017;9:880&#x2013;889. doi: 10.15252/emmm.201607298.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607298</ArticleId><ArticleId IdType="pmc">PMC5494517</ArticleId><ArticleId IdType="pubmed">28490573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugita S, et al. VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Skelet. Muscle. 2016;6:1&#x2013;17. doi: 10.1186/s13395-016-0105-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-016-0105-7</ArticleId><ArticleId IdType="pmc">PMC5050580</ArticleId><ArticleId IdType="pubmed">27713817</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Carroll D, et al. A slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 2007;21:1999&#x2013;2004. doi: 10.1101/gad.1565607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1565607</ArticleId><ArticleId IdType="pmc">PMC1948855</ArticleId><ArticleId IdType="pubmed">17626790</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez NJ, Gregory RI. Argonaute2 expression is post-transcriptionally coupled to microRNA abundance. RNA. 2013;19:605&#x2013;612. doi: 10.1261/rna.036434.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.036434.112</ArticleId><ArticleId IdType="pmc">PMC3677276</ArticleId><ArticleId IdType="pubmed">23485552</ArticleId></ArticleIdList></Reference><Reference><Citation>Smibert P, Yang J-S, Azzam G, Liu J-L, Lai EC. Homeostatic control of Argonaute stability by microRNA availability. Nat. Struct. Mol. Biol. 2013;20:789&#x2013;795. doi: 10.1038/nsmb.2606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2606</ArticleId><ArticleId IdType="pmc">PMC3702675</ArticleId><ArticleId IdType="pubmed">23708604</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershoni-Emek N, et al. Localization of RNAi machinery to axonal branch points and growth cones is facilitated by mitochondria and is disrupted in ALS. Front. Mol. Neurosci. 2018;11:311. doi: 10.3389/fnmol.2018.00311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00311</ArticleId><ArticleId IdType="pmc">PMC6134038</ArticleId><ArticleId IdType="pubmed">30233312</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N, et al. ALS along the axons&#x2014;expression of coding and noncoding RNA differs in axons of ALS models. Sci. Rep. 2017;7:44500. doi: 10.1038/srep44500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44500</ArticleId><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M, et al. Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol. Commun. 2020;8:1&#x2013;16. doi: 10.1186/s40478-020-00987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00987-6</ArticleId><ArticleId IdType="pmc">PMC7379803</ArticleId><ArticleId IdType="pubmed">32709255</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Aguila J, Hoogstraaten R, Kee N, Hedlund E. Axon-Seq decodes the motor axon transcriptome and its modulation in response to ALS. Stem Cell Rep. 2018;11:1565&#x2013;1578. doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro R, et al. Specific labeling of synaptic schwann cells reveals unique cellular and molecular features. Elife. 2020;9:1&#x2013;19. doi: 10.7554/eLife.56935.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.56935</ArticleId><ArticleId IdType="pmc">PMC7316509</ArticleId><ArticleId IdType="pubmed">32584256</ArticleId></ArticleIdList></Reference><Reference><Citation>Boettger T, W&#xfc;st S, Nolte H, Braun T. The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle. Skelet. Muscle. 2014;4:1&#x2013;13. doi: 10.1186/s13395-014-0023-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-014-0023-5</ArticleId><ArticleId IdType="pmc">PMC4272821</ArticleId><ArticleId IdType="pubmed">25530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Taetzsch T, et al. The microRNA miR-133b functions to slow Duchenne muscular dystrophy pathogenesis. J. Physiol. 2021;599:171&#x2013;192. doi: 10.1113/JP280405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP280405</ArticleId><ArticleId IdType="pmc">PMC8418193</ArticleId><ArticleId IdType="pubmed">32991751</ArticleId></ArticleIdList></Reference><Reference><Citation>La Rocca G, et al. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc. Natl. Acad. Sci. USA. 2015;112:767&#x2013;772. doi: 10.1073/pnas.1424217112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1424217112</ArticleId><ArticleId IdType="pmc">PMC4311832</ArticleId><ArticleId IdType="pubmed">25568082</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28:41&#x2013;51. doi: 10.1016/S0896-6273(00)00084-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)00084-2</ArticleId><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones RA, et al. Correction to NMJ-morph reveals principal components of synaptic morphology influencing structure&#x2013;function relationships at the neuromuscular junction. Open Biol. 2016;6:160240. doi: 10.1098/rsob.160335).</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.160335)</ArticleId><ArticleId IdType="pmc">PMC5204123</ArticleId><ArticleId IdType="pubmed">27927794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserstein RL, et al. Moving to a world beyond &#x201c;p &lt; 0.05. Res. Theory Nurs. Pract. 2019;1305:0&#x2013;19.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>